In a report released yesterday, David S Macdonald from SunTrust Robinson reiterated a Hold rating on Tenet Healthcare (NYSE: THC), with a price target of $35. The company’s shares closed yesterday at $32.41.
According to TipRanks.com, Macdonald is a 5-star analyst with an average return of 15.8% and a 73.0% success rate. Macdonald covers the Services sector, focusing on stocks such as Encompass Health Corporation, Walgreens Boots Alliance, and WellCare Health Plans.
Tenet Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $36.86, which is a 13.7% upside from current levels. In a report released yesterday, Piper Jaffray also reiterated a Hold rating on the stock with a $34 price target.
.
See today’s analyst top recommended stocks >>
Based on Tenet Healthcare’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $4.51 billion and net profit of $26 million. In comparison, last year the company earned revenue of $4.8 billion and had a GAAP net loss of $55 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities.
